参考文献/References:
[1] Essebag V,Verma A,Healey JS,et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study[J]. J Am Coll Cardiol,2016,67(11):1300-1308.
[2] Uslan DZ,Gleva MJ,Warren DK,et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry[J]. Pacing Clin Electrophysiol,2012,35(1):81-87.
[3] Malecka B,Kutarski A,Pietura R,et al. Complications of permanent dual-chamber pacing such as late purulent pacemaker pocket infection with broken and looped atrial lead,complicated by pulmonary embolism after transvenous lead removal: a case report[J]. Pol Arch Med Wewn,2008,118(5):322-326.
[4] Kutinsky IB,Jarandilla R,Jewett M,et al. Risk of hematoma complications after device implant in the clopidogrel era[J]. Circ Arrhythm Electrophysiol,2010,3(4):312-318.
[5] Mond HG,Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia’s project[J]. Pacing Clin Electrophysiol,2011,34(8):1013-1027.
[6] Wiegand UK,Lejeune D,Boguschewski F,et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity,operation strategy,and perioperative antiplatelet/anticoagulation therapy[J]. Chest,2004,126(4):1177-1186.
[7] 国建萍,王玉堂,单兆亮,等. 起搏器囊袋血肿相关危险因素分析[C]//.中华医学会心电生理和起搏分会第十次全国学术年会会议汇编.2012:68-69.
[8] Glikson M,Nielsen JC,Kronborg MB,et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J,2021,42(35):3427-3520.
[9] Birnie DH,Healey JS,Wells GA,et al. Pacemaker or defibrillator surgery without interruption of anticoagulation[J]. N Engl J Med,2013,368(22):2084-2093.
[10] Tolosana JM,Berne P,Mont L,et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial[J]. Eur Heart J,2009,30(15):1880-1884.
[11] Cheng A,Nazarian S,Brinker JA,et al. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial[J]. Heart Rhythm,2011,8(4):536-540.
[12] Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.
[13] Traykov V,Bongiorni MG,Boriani G,et al. Clinical practice and implementation of guidelines for the prevention,diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association[J]. Europace,2019,21(8):1270-1279.
[14] Da CA,Lelievre H,Kirkorian G,et al. Role of the preaxillary flora in pacemaker infections: a prospective study[J]. Circulation,1998,97(18):1791-1795.
[15] Sticherling C,Marin F,Birnie D,et al. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis,Heart Rhythm Society (HRS),and Asia Pacific Heart Rhythm Society (APHRS)[J]. Europace,2015,17(8):1197-1214.
[16] Wei Y,Cai L,Wu X,et al. Sub-pocket small-hole drainage for pocket hematoma after cardiac device implantation[J]. Herz,2022,47(1):63-66.
[17] 李亚文,李世军,王琳,等. 植入永久性心脏起搏器术后血肿观察及影响因素研究[J]. 中国医疗器械信息,2019,25(10):55-56.
[18] 杨婷,杨平. 老年患者安装永久起搏器的围手术期护理[J]. 中国病案,2013,14(8):32-33.
[19] 徐晓华,张贤,沈燕萍,等. 无导线起搏器植入患者的围术期护理[J]. 齐鲁护理杂志,2020,26(6):122-124.
[20] Birnie DH,Healey JS,Wells GA,et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery,in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)[J]. Eur Heart J,2018,39(44):3973-3979.
[21] Haeberlin A,Kozhuharov N,Knecht S,et al. Leadless pacemaker implantation quality: importance of the operator’s experience[J]. Europace,2020,22(6):939-946.
[22] Longo F,Piliego C,Agro FE. Ultrasound aided repositioning of misplaced guidewire during subclavian vein catheterisation[J]. J Vasc Access,2019,20(6):769-770.
[23] Emmel M,Sreeram N,Brockmeier K,et al. Superior vena cava stenting and transvenous pacemaker implantation (stent and pace) after the Mustard operation[J]. Clin Res Cardiol,2007,96(1):17-22.
[24] Okada M,Kashiwase K,Hirata A,et al. Bacterial contamination during pacemaker implantation is common and does not always result in infection[J]. Circ J,2015,79(8):1712-1718.